NCT06968572View on ClinicalTrials.gov

Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion

PHASE1RecruitingINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

April 11, 2025

Primary Completion Date

March 26, 2026

Study Completion Date

May 8, 2028

Conditions
Advanced Solid Tumors
Interventions
DRUG

HSK41959

Oral administration, QD

Trial Locations (3)

200120

RECRUITING

Shanghai East Hospital, Shanghai

Unknown

NOT_YET_RECRUITING

The Affiliated Hospital of Guizhou Medical University, Guiyang

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY